Company Overview
Accuracy and Efficiency. Together.We are a leading global developer and provider of innovative molecular and immunodiagnostic products focused on Infectious and Gastroenterological Diseases. We are a trusted partner creating value for research and clinical laboratories with high-quality, user-frien...
Specialties
See our solutions for your area of research or type of clinical testingALPCO’s expertise and wide variety of platforms and products can enhance your research and diagnostics. Choose your area of focus and explore our extensive collection of resources, instruments, and assays.Specialty AllergyAllerge...
Ampersand Capital Partners Acquires American Laboratory Products Company
FOR IMMEDIATE RELEASE
Salem, NH – September 21, 2020: American Laboratory Products Company, Ltd. (ALPCO), a specialty in vitro diagnostics company, today announced the majority recapitalization of the company by Ampersand Capital Partners. Ampersand’s investment will be used to support ALPCO’s wo...
American Laboratory Products Company Merges with GeneProof
SALEM, NH and BRNO, Czech Republic – April 21st, 2022: American Laboratory Products Company, Ltd. (“ALPCO”), a specialty in vitro diagnostics company, today announced a merger with GeneProof a.s. (“GeneProof”), a leading molecular diagnostics company based in Brno, Czech Republic. The combination cr...
Life Science and Clinical Diagnostics Solutions
Product Portfolio: Over 600 Kits to Measure Important Biomarkers. We are continuously expanding our portfolio of life sciences and clinical diagnostic solutions in support of the research community. ALPCO currently offers over 600 kits to measure important biomarkers in multiple species and sample t...
ALPCO-GeneProof Appoints Erik M. Allen as Chief Executive Officer
SALEM, N.H. and BRNO, Czech Republic, March 30, 2023 /PRNewswire/ -- American Laboratory Products Company, Ltd. ("ALPCO", or the "Company"), a global provider of specialty diagnostic solutions, today announced the appointment of Erik M. Allen as Chief Executive Officer (CEO). Mr....
GeneProof Announces Expansion of its IVDR-Certified PCR Portfolio
GeneProof, a leader in molecular diagnostics, today announced the addition of six new IVDR-certified PCR kits to its expansive portfolio. This comes as a testament to the company’s dedication to delivering its entire portfolio of approximately 80 products as IVDR compliant by 2027. Currently, ...